m-PEG9-CH2COOH

CAS No. 405518-55-0

m-PEG9-CH2COOH( —— )

Catalog No. M26978 CAS No. 405518-55-0

m-PEG9-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 87 Get Quote
200MG 133 Get Quote
500MG 202 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    m-PEG9-CH2COOH
  • Note
    Research use only, not for human use.
  • Brief Description
    m-PEG9-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    m-PEG9-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • In Vitro
    PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    AMPA| Kainate receptor| NMDA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    405518-55-0
  • Formula Weight
    486.555
  • Molecular Formula
    C21H42O12
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COCCOCCOCCOCCOCCOCCOCCOCCOCCOCC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Weber M, Bonaventure N, Sahel JA. Protective role of excitatory amino acid antagonists in experimental retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 1995 Jun;233(6):360-5.
molnova catalog
related products
  • Compound 35

    Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses.Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. Compounds 35 have shown good metabolic stability in plasma and liver microsomes (rat and human), and 32 did not inhibit CYP3A4 nor CYP2C9.

  • Mitochondrial fusion...

    Mitochondrial fusion promoter M1 is a mitochondrial dynamic modulator.

  • NubO (68–75), Ndufa4...

    NubO (68–75), Ndufa4 (68–75)